RARITY OF ONCOGENIC MUTATIONS IN THE THYROTROPIN RECEPTOR OF AUTONOMOUSLY FUNCTIONING THYROID-NODULES IN JAPAN

被引:76
作者
TAKESHITA, A
NAGAYAMA, Y
YOKOYAMA, N
ISHIKAWA, N
ITO, K
YAMASHITA, T
OBARA, T
MURAKAMI, Y
KUMA, K
TAKAMATSU, J
OHSAWA, N
NAGATAKI, S
机构
[1] NAGASAKI UNIV, SCH MED, DEPT INTERNAL MED 1, NAGASAKI 852, JAPAN
[2] NAGASAKI UNIV, SCH MED, INST ATOM DIS, DEPT CELL PHYSIOL, NAGASAKI 852, JAPAN
[3] ITO HOSP, TOKYO, JAPAN
[4] TOKYO WOMENS MED COLL, DEPT ENDOCRINE SURG, TOKYO, JAPAN
[5] KUMA HOSP, KOBE, JAPAN
[6] OSAKA MED COLL, DEPT INTERNAL MED 1, TAKATSUKI, OSAKA, JAPAN
关键词
D O I
10.1210/jc.80.9.2607
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Constitutively activating mutations have recently been identified in the thyrotropin receptor (TSHR) of hyperfunctioning thyroid adenomas and familial hyperthyroidism. In the present study, we evaluated the frequency of constitutively activating TSHR mutations in a large series of autonomously functioning thyroid nodules (AFTNs) in Japan. Forty-five AFTNs (38 solitary hyperfunctioning thyroid adenomas and 7 toxic multinodular goiters) were analyzed. Genomic DNA was extracted from paraffin-embedded tissue sections, from which DNA fragments encoding the mutational hot spots of the receptor (the third cytoplasmic loop and the sixth transmembrane segment) were amplified by polymerase chain reaction. In the single-stranded conformation polymorphism (SSCP) analysis, only one hyperfunctioning adenoma (no. 21) displayed a migration abnormality. In sequence analysis, an unusual mutation of alternate three-base deletions at nucleotides 1953-1957 (AAA GAT ACC to AAG TCC), resulting in one amino acid deletion (Asp at 619) and one conservative amino acid substitution (Thr to Ser at 620), was identified in tumor DNA but not in leukocyte DNA of no. 21. Further, the normal sequence in these regions was confirmed in 10 randomly selected samples with normal migrating patterns in SSCP analysis. The functional property of the mutant with Delta 619 and T620S (designated TSHR Delta 619) was then evaluated with in. vitro mutagenesis and transfection studies. Unexpectedly, however, there were no significant differences in TSH binding affinity, and basal and TSH-stimulated levels of cAMP and inositol 1,4,5-triphosphate between the TSHR Delta 619 and the wt-TSHR. In conclusion, the incidence of the constitutively activating TSHR mutations in AFTNs appears to be low in Japan. The oncogenic potential of a novel somatic mutant TSHR Delta 619 identified in a hyperfunctioning adenoma in this study is at present uncertain because of its intact function.
引用
收藏
页码:2607 / 2611
页数:5
相关论文
共 28 条
[1]   G-PROTEIN-COUPLED RECEPTOR GENES AS PROTOONCOGENES - CONSTITUTIVELY ACTIVATING MUTATION OF THE ALPHA-1B-ADRENERGIC RECEPTOR ENHANCES MITOGENESIS AND TUMORIGENICITY [J].
ALLEN, LF ;
LEFKOWITZ, RJ ;
CARON, MG ;
COTECCHIA, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (24) :11354-11358
[2]  
CHAZENBALK GD, 1990, J BIOL CHEM, V265, P20970
[3]   THE FUNCTIONAL EXPRESSION OF RECOMBINANT HUMAN THYROTROPIN RECEPTORS IN NONTHYROIDAL EUKARYOTIC CELLS PROVIDES EVIDENCE THAT HOMOLOGOUS DESENSITIZATION TO THYROTROPIN STIMULATION REQUIRES A CELL-SPECIFIC FACTOR [J].
CHAZENBALK, GD ;
NAGAYAMA, Y ;
KAUFMAN, KD ;
RAPOPORT, B .
ENDOCRINOLOGY, 1990, 127 (03) :1240-1244
[4]   PHYSIOLOGICAL AND PATHOLOGICAL REGULATION OF THYROID-CELL PROLIFERATION AND DIFFERENTIATION BY THYROTROPIN AND OTHER FACTORS [J].
DUMONT, JE ;
LAMY, F ;
ROGER, P ;
MAENHAUT, C .
PHYSIOLOGICAL REVIEWS, 1992, 72 (03) :667-697
[5]   GERMLINE MUTATIONS IN THE THYROTROPIN RECEPTOR GENE CAUSE NON-AUTOIMMUNE AUTOSOMAL-DOMINANT HYPERTHYROIDISM [J].
DUPREZ, L ;
PARMA, J ;
VANSANDE, J ;
ALLGEIER, A ;
LECLERE, J ;
SCHVARTZ, C ;
DELISLE, MJ ;
DECOULX, M ;
ORGIAZZI, J ;
DUMONT, J ;
VASSART, G .
NATURE GENETICS, 1994, 7 (03) :396-401
[6]   MUTATIONAL ACTIVATION OF RAS AND GSP ONCOGENES IN DIFFERENTIATED THYROID-CANCER AND THEIR BIOLOGICAL IMPLICATIONS [J].
GORETZKI, PE ;
LYONS, J ;
STACYPHIPPS, S ;
ROSENAU, W ;
DEMEURE, M ;
CLARK, OH ;
MCCORMICK, F ;
ROHER, HD ;
BOURNE, HR .
WORLD JOURNAL OF SURGERY, 1992, 16 (04) :576-582
[7]   PTC IS A NOVEL REARRANGED FORM OF THE RET PROTO-ONCOGENE AND IS FREQUENTLY DETECTED INVIVO IN HUMAN THYROID PAPILLARY CARCINOMAS [J].
GRIECO, M ;
SANTORO, M ;
BERLINGIERI, MT ;
MELILLO, RM ;
DONGHI, R ;
BONGARZONE, I ;
PIEROTTI, MA ;
DELLAPORTA, G ;
FUSCO, A ;
VECCHIO, G .
CELL, 1990, 60 (04) :557-563
[8]  
HAY ID, 1991, THYROID FUNDAMENTAL, P698
[9]  
KJELSBERG MA, 1992, J BIOL CHEM, V267, P1430
[10]   BRIEF REPORT - CONGENITAL HYPERTHYROIDISM CAUSED BY A MUTATION IN THE THYROTROPIN-RECEPTOR GENE [J].
KOPP, P ;
VANSANDE, J ;
PARMA, J ;
DUPREZ, L ;
GERBER, H ;
JOSS, E ;
JAMESON, JL ;
DUMONT, JE ;
VASSART, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (03) :150-154